Analgesia and anesthesia for the ill or injured dog and cat

Content: Intro
 Title Page
 Copyright Page
 Contents
 List of Contributors
 Preface
 Acknowledgements
 Chapter 1 General Considerations for Pain Management upon Initial Presentation and during Hospital Stay
 References
 Further Reading
 Chapter 2 Physiology and Pathophysiology of Pain
 I. Pain versus Nociception
 II. The Pain Pathway in Physiologic Pain
 A. Transduction
 B. Transmission
 C. Modulation
 D. Perception
 E. Endogenous Analgesic Pathways
 III. The Pain Pathway in Pathologic Pain
 A. Transduction
 B. Transmission
 C. Modulation
 D. Perception
 E. Descending Inhibitory Pathway IV. Specific Types of PainA. Neonatal/Pediatric Pain
 B. Neuropathic Pain
 C. Visceral Pain
 D. Breakthrough Pain
 E. Stimulus-Evoked/Movement-Evoked Pain
 References
 Further Reading
 Chapter 3 Physiologic and Pharmacologic Applications to Manage Neuropathic Pain
 I. Physiology of Neuropathic Pain
 A. The Patient's Experience
 B. The Quality and Pattern of Altered Sensitivity
 C. Immune Response Mechanisms in Neuropathic Pain
 D. Endogenous Descending Facilitatory Systems [8]
 E. Descending Inhibitory Pathway [9]
 F. To Summarize Neuropathic Pain II. Clinical Relevance of Physiology to PharmacologyA. Opioids/Opiates
 B. Tricyclic Antidepressant Analgesic (TCA) Effects
 C. Gabapentin
 D. NMDA Receptor Antagonists
 E. Local Anesthetics
 F. Alpha2 Adrenergic (Alpha2) Agonists
 G. Nonsteroidal Anti-Inflammatory Analgesics (NSAIAs)
 H. Acupuncture
 III. Diagnosing Neuropathic Pain
 IV. Neuropathic Pain Associated Conditions
 A. Neuropathic Pain Associated with Trauma: Accidental and Surgical
 B. Lumbosacral Lesions
 C. Spinal Cord Injury
 D. Potential Sources of Neck and Back Pain in Cats and Dogs V. Primary Lesions of the Peripheral or central Nervous SystemA. Peripheral Nervous System
 B. Central Pain Syndrome
 VI. Neuropathic Pain and Management of Visceral Origin
 VII. Treatment
 A. Acute Pain Management
 B. Chronic Neuropathic Pain Management
 VIII. Future Therapeutic Modalities
 A. Vanilloid Receptor 1 Antagonists
 B. Serotonin and Norepinephrine Re‐Uptake Inhibitor Mixed Compound
 IX. Conclusion
 References
 Further Reading
 Chapter 4 Physiology and Pharmacology: Clinical Application to Abdominal and Pelvic Visceral Pain
 I. Neurophysiology Reviews [1-3] A. Afferent and Efferent InnervationsB. Autonomic Nervous System [4]
 C. Central Processing [2]
 D. Peripheral Sensitization
 E. Central Sensitization (Inflammation-Induced)
 II. Clinical Relevance of Physiology to Pharmacology
 A. Dorsal Horn Targets for Analgesics [3]
 B. Peripheral Sensitization Targets for Analgesics
 C. Reduction/Modulation of the Transmission of Nociceptive Information
 D. Epidural Site for Analgesic Administration
 III. Sources of Abdominal Pain
 A. Gastrointestinal System
 B. Urogenital System
 IV. Pelvis and Perineum [3, 5]
 A. Pelvis